Skip to main content
ChemPartner PharmaTech Co., Ltd. logo

ChemPartner PharmaTech Co., Ltd. — Investor Relations & Filings

Ticker · 300149 ISIN · CNE100000Y27 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,256 across all filing types
Latest filing 2018-03-09 Proxy Solicitation & In…
Country CN China
Listing Shenzhen Stock Exchange 300149

About ChemPartner PharmaTech Co., Ltd.

https://www.chempartner.com

ChemPartner PharmaTech Co., Ltd. is a global research and development organization providing comprehensive drug discovery and development services. Operating as a Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), the company supports pharmaceutical and biotechnology clients through an integrated service platform. Core capabilities include medicinal chemistry, biology, pharmacology, drug metabolism and pharmacokinetics (DMPK), and toxicology. The organization also offers specialized expertise in biologics discovery, protein engineering, and antibody development. ChemPartner facilitates the transition from early-stage research to clinical development through its pharmaceutical development and manufacturing capabilities, utilizing advanced technology to accelerate the discovery and production of novel therapeutic agents.

Recent filings

Filing Released Lang Actions
关于召开2018年第二次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice about convening the 2018 second extraordinary general meeting of shareholders for Quantum Hi-Tech (China) Biological Co., Ltd. It includes information about the meeting date, agenda items, voting procedures (both in-person and online), registration details, and attachments such as proxy forms and shareholder registration forms. There is no financial data or report content; rather, it is an announcement and procedural guide for a shareholder meeting. This fits the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA) or a Proxy Solicitation & Information Statement (PSI). However, since it is a notice about the meeting and voting procedures rather than the solicitation materials or proxy statement itself, and it is not the actual voting results, the best fit is Proxy Solicitation & Information Statement (PSI). The document length is under 5,000 characters, but it contains substantive meeting and voting information, not just a brief announcement, so it is not a Report Publication Announcement (RPA). Therefore, the classification is PSI with high confidence.
2018-03-09 Chinese
关于继续开展期货套期保值业务的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company about continuing its futures hedging business, specifically related to sugar futures. It details the purpose, necessity, risk analysis, risk control measures, and approvals related to the hedging activities. The document includes board and supervisory committee meeting resolutions approving the hedging business. It does not contain financial statements or quarterly/yearly financial results, nor is it a transcript or presentation. It is a regulatory announcement about a specific business activity and risk management, not a financial report or earnings release. The document length is 3177 characters, which is relatively short and focused on a specific operational update. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2018-03-09 Chinese
第三届监事会第二十八次会议决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of Quantum Hi-Tech (量子高科) regarding decisions made in their 28th meeting. It includes voting results on financial management proposals such as use of idle funds and hedging activities. The document is short (1222 characters), formal, and focuses on board meeting resolutions and approvals. It does not contain financial statements, earnings data, or detailed financial analysis. It is not an annual or interim report, nor an earnings release. It is not a proxy solicitation or voting results announcement for shareholders, but a board/management information disclosure about internal supervisory board decisions. Therefore, the best fitting category is Board/Management Information (MANG).
2018-03-09 Chinese
2017年度业绩快报
Earnings Release Classification · 95% confidence The document is titled '2017 年度业绩快报' which translates to '2017 Annual Performance Express Report' or '2017 Annual Earnings Quick Report'. It contains preliminary financial data for the year 2017, including revenue, profit, net income, and asset figures. The text explicitly states that the data is preliminary, unaudited, and may differ from the final annual report. It also mentions that the detailed financial data will be disclosed in the 2017 Annual Report. The document is relatively short (1613 characters) and serves as an initial earnings announcement rather than a full annual report. This matches the definition of an Earnings Release (ER), which is an initial announcement of quarterly or periodical financial results with key highlights only. Therefore, the document should be classified as an Earnings Release (ER).
2018-02-27 Chinese
关于收到《中国证监会行政许可申请受理单》的公告
Capital/Financing Update Classification · 95% confidence The document is a short announcement (654 characters) about the company receiving an administrative license acceptance notice from the China Securities Regulatory Commission regarding an application for approval of issuance of shares to purchase assets. It states that the approval is pending and there is uncertainty about the timing and outcome. The document does not contain financial statements or detailed financial data, nor is it a full report. It is an update on a regulatory approval process related to capital issuance and asset purchase. Given the content and length, it fits best as a Capital/Financing Update (CAP) rather than a full report or regulatory filing. It is not a report publication announcement or certification. Therefore, the classification is CAP with high confidence.
2018-02-09 Chinese
关于取得商务主管部门关于外国投资者战略投资上市公司的备案的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the company's receipt of approval from the commerce authority for a foreign investor's strategic investment in the listed company. It references prior disclosures related to a share issuance and asset purchase transaction, but this document itself is an update on regulatory approval status and does not contain financial statements or detailed financial data. The document length is short (891 characters) and it serves as a formal announcement of a regulatory milestone in a capital transaction. Therefore, it fits best under Capital/Financing Update (CAP).
2018-02-04 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.